Emerald Mutual Fund Advisers Trust Corcept Therapeutics Inc Transaction History
Emerald Mutual Fund Advisers Trust
- $1.47 Billion
- Q2 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 150,906 shares of CORT stock, worth $13.3 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
150,906
Previous 37,818
299.03%
Holding current value
$13.3 Million
Previous $4.32 Million
156.45%
% of portfolio
0.75%
Previous 0.35%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
469Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.46 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$856 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$683 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$554 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$342 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.47B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...